{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:48:28Z","timestamp":1783529308578,"version":"3.55.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871242"],"award-info":[{"award-number":["81871242"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Invasive pulmonary aspergillosis (IPA) is common in immuno-compromised people, and a high incidence of IPA has been found in patients with severe fever with thrombocytopenia syndrome (SFTS). Our study aimed to determine the independent risk factors for IPA and the relationship between smoking status and the risk of IPA in SFTS patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective analysis of SFTS patients in the First Affiliated Hospital of Nanjing Medical University from May 2011 to December 2021 was reviewed. The patients were divided into two groups: IPA and non-IPA groups. We compared demographic characteristics, clinical manifestation, laboratory parameters, treatment, and prognosis, and explored the risk factors of IPA using logistic regression and ROC curve. The dose-dependent effect of smoking on the risk of IPA was further estimated, including the age of smoking initiation, daily smoking amount, smoking duration, and pack-years of smoking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 189 individuals were included. Compared with the non-IPA group, the IPA group had higher levels of smoking, drinking, cough, dyspnea, aCCI scores, Dabie bandavirus (DBV) RNA load, ferritin, PCT, IL-6, APTT, LDH, BUN, creatinine, and lower levels of FT4 and TSH. The incidences of MODS, admission to ICU, ventilation, and broad-spectrum antibiotic treatment were significantly higher in the IPA group than in the non-IPA group. Multivariable logistic analysis showed that smoking history, cough, creatinine, admission to ICU, broad-spectrum, and corticosteroid therapies were the independent risk factors for IPA in SFTS patients. We further confirmed that the age of smoking initiation &amp;lt;30 years, smoking at least one pack per day, smoking for at least 40 years, and having at least 40 pack-years of smoking exposure were the independent risk factors for IPA among smokers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The prognosis of SFTS patients in the IPA group is worse than that of the non-IPA group. Attention should be paid to SFTS patients with a smoking history, cough, creatinine, admission to ICU, and broad-spectrum and corticosteroid therapies. There is a strong dose-dependent association between smoking and IPA development in SFTS patients. Prophylactic antifungal therapy should be considered for SFTS patients with these risk factors, but further studies are necessary to determine if it is beneficial for the prognosis of these patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmicb.2023.1209705","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T18:14:55Z","timestamp":1688148895000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["The dose\u2013response relationship between smoking and the risk factor for invasive pulmonary aspergillosis in patients with severe fever with thrombocytopenia syndrome"],"prefix":"10.3389","volume":"14","author":[{"given":"Yan","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinqin","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1093\/cid\/ciz673","article-title":"Invasive pulmonary aspergillosis in patients with severe fever with thrombocytopenia syndrome","volume":"70","author":"Bae","year":"2020","journal-title":"Clin. Infect Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/myc.13434","article-title":"COVID-19-associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID-19 patients","volume":"65","author":"Calder\u00f3n-Parra","year":"2022","journal-title":"Mycoses."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1007\/s00253-021-11183-4","article-title":"A roadmap from unknowns to knowns: advancing our understanding of the microbiomes of commercially available tobacco products","volume":"105","author":"Chattopadhyay","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s40249-022-01017-4","article-title":"Transmission and mortality risk assessment of severe fever with thrombocytopenia syndrome in China: results from 11-years' study","volume":"11","author":"Chen","year":"2022","journal-title":"Infect Dis. Poverty."},{"key":"B5","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jiac.2018.01.005","article-title":"Clinical features of fatal severe fever with thrombocytopenia syndrome that is complicated by invasive pulmonary aspergillosis","volume":"24","author":"Chen","year":"2018","journal-title":"J. Infect Chemother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jmii.2018.09.006","article-title":"Invasive mold infections in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"52","author":"Chien","year":"2019","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"5933","DOI":"10.1002\/jmv.28093","article-title":"Coinfections in hospitalized patients with severe fever with thrombocytopenia syndrome: a retrospective study","volume":"94","author":"Ge","year":"2022","journal-title":"J. Med. Virol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1002\/jmv.26877","article-title":"Changes in peripheral blood cytokines in patients with severe fever with thrombocytopenia syndrome","volume":"93","author":"He","year":"2021","journal-title":"J. Med. Virol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"576640","DOI":"10.3389\/fimmu.2021.576640","article-title":"Early-warning immune predictors for invasive pulmonary aspergillosis in severe patients with severe fever with thrombocytopenia syndrome","volume":"12","author":"Hu","year":"2021","journal-title":"Front. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3390\/v13061086","article-title":"Severe fever with thrombocytopenia syndrome accompanied by invasive pulmonary aspergillosis: an autopsy case","volume":"13","author":"Iwao","year":"2021","journal-title":"Viruses"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0009128","DOI":"10.1371\/journal.pntd.0009128","article-title":"Effects of steroid therapy in patients with severe fever with Thrombocytopenia syndrome: a multicenter clinical cohort study","volume":"15","author":"Jung","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/v13050785","article-title":"Corticosteroids may have negative effects on the management of patients with severe fever with thrombocytopenia syndrome: a case-control study","volume":"13","author":"Kawaguchi","year":"2021","journal-title":"Viruses"},{"key":"B14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/v13010010","article-title":"Prognostic factors of severe fever with thrombocytopenia syndrome in South Korea","volume":"13","author":"Kim","year":"","journal-title":"Viruses"},{"key":"B15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4103\/IJCIIS.IJCIIS_96_19","article-title":"Severe fever with thrombocytopenia syndrome (SFTS) associated with invasive pulmonary Aspergillosis in a patient with a low CD4+ T-cell count: a case report","volume":"10","author":"Kim","year":"","journal-title":"Int. J. Crit. Illn. Inj. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S1473-3099(18)30293-7","article-title":"Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study","volume":"18","author":"Li","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3760\/cma.j.issn.1674-2397.2011.04.001","article-title":"Guideline for prevention and treatment of sever fever with thrombocytopenia syndrome (2010 vesrion)","volume":"4","year":"2011","journal-title":"Chin. J. Clin. Infect Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/ndt\/gfac270","article-title":"Cadmium, active smoking and renal function deterioration in patients with type 2 diabetes","volume":"38","author":"Oosterwijk","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1093\/cid\/ciaa001","article-title":"Smoking as a risk factor of invasive fungal disease: systematic review and meta-analysis","volume":"71","author":"Pourbaix","year":"2020","journal-title":"Clin. Infect Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.2169\/internalmedicine.3257-19","article-title":"Severe fever with thrombocytopenia syndrome complicated with pseudomembranous aspergillus tracheobronchitis in a patient without apparent risk factors for invasive aspergillosis","volume":"58","author":"Sakaguchi","year":"2019","journal-title":"Intern. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4046\/trd.2022.0030","article-title":"Proven nasal and pulmonary aspergillosis in patient with severe fever with thrombocytopenia syndrome","volume":"85","author":"Seong","year":"2022","journal-title":"Tuberc. Respir. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jmii.2020.12.016","article-title":"Proven invasive pulmonary aspergillosis in the early clinical course of severe fever with thrombocytopenia syndrome: Importance of an early diagnosis","volume":"54","author":"Seong","year":"2021","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/myc.13410","article-title":"Incidence, risk factors and mortality of invasive pulmonary aspergillosis in patients with influenza: a systematic review and meta-analysis","volume":"65","author":"Shi","year":"2022","journal-title":"Mycoses."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/s41598-023-28851-2","article-title":"Investigation of predictors for invasive pulmonary aspergillosis in patients with severe fever with thrombocytopenia syndrome","volume":"13","author":"Song","year":"2023","journal-title":"Sci. Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/infdis\/jis743","article-title":"Aspergillus fumigatus activates thrombocytes by secretion of soluble compounds","volume":"207","author":"Speth","year":"2013","journal-title":"J. Infect Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"907888","DOI":"10.3389\/fmicb.2022.907888","article-title":"NLR, a convenient early-warning biomarker of fatal outcome in patients with severe fever with thrombocytopenia syndrome","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1634","DOI":"10.1093\/cid\/ciaa1298","article-title":"A National strategy to diagnose coronavirus disease 2019-associated invasive fungal disease in the intensive care unit","volume":"73","author":"White","year":"2021","journal-title":"Clin. Infect Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.ijid.2021.02.088","article-title":"Invasive pulmonary aspergillosis is a frequent complication in patients with severe fever with thrombocytopenia syndrome: a retrospective study","volume":"105","author":"Xu","year":"2021","journal-title":"Int. J. Infect Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.3390\/ijerph19042271","article-title":"Clinical presentation and mortality of severe fever with thrombocytopenia syndrome in Japan: a systematic review of case reports","volume":"19","author":"Yokomizo","year":"2022","journal-title":"Int. J. Environ. Res. Public Health."},{"key":"B30","doi-asserted-by":"publisher","first-page":"711847","DOI":"10.3389\/fimmu.2021.711847","article-title":"IL-6 and IL-10 levels, rather than viral load and neutralizing antibody titers, determine the fate of patients with severe fever with thrombocytopenia syndrome virus infection in South Korea","volume":"12","author":"Yoo","year":"2021","journal-title":"Front. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1056\/NEJMoa1010095","article-title":"Fever with thrombocytopenia associated with a novel bunyavirus in China","volume":"364","author":"Yu","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"129531","DOI":"10.1172\/jci.insight.129531","article-title":"Genetic and pathogenic diversity of severe fever with thrombocytopenia syndrome virus (SFTSV) in South Korea","volume":"5","author":"Yun","year":"2020","journal-title":"JCI Insight."},{"key":"B33","doi-asserted-by":"publisher","first-page":"5916","DOI":"10.1002\/jmv.28059","article-title":"Associated microbiota and treatment of severe fever with thrombocytopenia syndrome complicated with infections","volume":"94","author":"Zhang","year":"2022","journal-title":"J. Med. Virol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1002\/jmv.26544","article-title":"Severe fever with thrombocytopenia syndrome in Hefei: Clinical features, risk factors, and ribavirin therapeutic efficacy","volume":"93","author":"Zhang","year":"2021","journal-title":"J. Med. Virol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1093\/infdis\/jiz682","article-title":"Invasive pulmonary aspergillosis in adults with avian influenza A (H7N9) pneumonia in China: a retrospective study","volume":"221","author":"Zou","year":"2020","journal-title":"J. Infect Dis."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1209705\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T18:15:01Z","timestamp":1688148901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1209705\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,30]]},"references-count":35,"alternative-id":["10.3389\/fmicb.2023.1209705"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2023.1209705","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,30]]},"article-number":"1209705"}}